Articles On Integral Diagnostics (ASX:IDX)

A “valuation disconnect” between groups of larger stocks on the ASX versus their smaller counterparts will throw up plenty of value opportunities in 2025, helped by an overdue pullback in global sharemarkets. That’s the view of the small an...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Today's update includes: -A Conflict In Waiting?-Banks And Super Fund...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel Pending MRI deregulation is behind the now approved merger of Integral Diagnosti...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US Equities had a weak session, but nothing like the growth stocks sell-off that occ...

Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (AS...

The latest round of broker upgrades on ASX All Ords shares are here and you may as well strap in because there's a few names to discuss. Brokers are bullish on companies ranging from the healthcare sector, to energy, to food, giving inv...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

ASX healthcare shares finished in the red on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) falling 1.11% while the S&P/ASX 200 Index (ASX: XJO) also tumbled 0.5%. In a recent note, fund manager IML identified th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8118.00 – 52.00 – 0.64% S&P ASX 200 8160.00...

Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential   The imaging sector is by no means the sexiest part...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Aidoc’s AI technology enhances radiology services at IDX, significantly improving...

  The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent...

The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent t...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The Dow Jones Industrial Average climbed to a record high overnight, as Wall Street attempted to recover from a steep sell-off earlier this month. The 30-stock index gained 243.63 points, or 0.59 per cent, closing at a new record of 41,335....

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ADH)) - Adair...

ASX healthcare stocks showed mixed results following the release of their most recent financials on Tuesday. Three companies in particular stand out, with two finishing in the green and one in the red. Integral Diagnostics Ltd (ASX: I...

As the 2024 fiscal year reporting season progresses, several key players across different sectors have revealed their financial performance, showcasing a mix of resilience and challenges. Diagnostic imaging provider Capitol Health, energy c...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

As another ASX reporting season unfolds, investors and financial analysts alike will spend the next several weeks keenly focused on dissecting company balance sheets to gauge the financial health and performance of ASX companies. We'll...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Highlights:  ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates.  Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The Bapcor Ltd (ASX: BAP) share price is having a tough time on Tuesday. In morning trade, the ASX 200 stock is down 4% to $4.85. What's going on? Investors have been hitting the sell button today after the auto parts retailer released a co...

Chalice Mining Ltd (ASX: CHN) shares are catching the eye on Wednesday. In morning trade, the ASX mining stock is up 8% to $1.64. Why is this ASX mining stock racing higher? Investors have been scrambling to buy the company's shares this mo...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday and storming higher. In afternoon trade, the benchmark index is up 0.95% to 7,773.6 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

The S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.76% to 8,003.8 points in early trading on Tuesday. As reported in The Australian, 3 All Ords stocks have just gained buy ratings from top brokers. Let's check them out. Capst...

Integral Diagnostics and Capitol Health have agreed to join forces and create a 155-clinic diagnostic imaging company.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,711.6 points. Four ASX shares that are falling more than most today are listed...

The market may be edging lower on Monday but that hasn't stopped one ASX All Ords stock from rocketing. In morning trade, the Capitol Health Ltd (ASX: CAJ) share price is up 20% to 29.5 cents. Why is this ASX All Ords stock rocketing? Inves...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

If you're looking to capitalise on the artificial intelligence (AI) revolution, you might consider investing in ASX healthcare shares. The Australian market has rallied behind AI stocks recently, and there may be many more beneficiaries...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

ASX 300 healthcare stock Integral Diagnostics Ltd (ASX: IDX) is up 1.43% to $2.49 per share on Thursday. Meantime, the S&P/ASX 300 Index (ASX: XKO) is up 0.65% to 7,607.7 points. Boutique investment manager Firetrail has identif...

  US markets kicked off the post Easter week by giving up ground on what was a winning month for March and a strong first quarter. New inflation data raised concerns that the Fed may struggle to hit its target of three rate cuts by the end...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from IML’s Marc W...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

  Local markets started slow before ripping into an all-time intraday high  10 of 11 sectors higher, benchmark closes 0.50pc up Small Caps led by Motio, Cue Energy and Sierra Rutile   Some strong earnings on the last day of February and...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((3PL)) - 3P Learning ((ADA)) - Adacel Technologies ((ANN)) - Ansell ((ARB)) - ARB Corp ((AUB)) - AUB Group ((BBN)) - Baby Bunting ((BHP)) - BHP Group ((BVS)) - Bravura So...

It's fair to say that ASX healthcare shares have flummoxed investors over the past couple of years. As interest rates headed up and consumers closed their wallets, many fund managers expected the health sector to outperform because of the...